The FTC and the Holy Grail: The Tipline for 31 March 2021
The Federal Trade Commission and Illumina are squaring off once again. This time, the agency is suing to block a vertical deal involving the world-leader in next-generation DNA sequencing. The commission alleges that Illumina’s purchase of Grail could allow it to raise prices or foreclose competition from rivals racing Grail to launch a new cancer screening test. Also in Tipline, Judge Amit Mehta encourages the Department of Justice to narrow its discovery demands from Google and the Antitrust Division files another round of criminal wage-fixing charges.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10